On July 27, local time, the 75th American Clinical Chemistry Annual Meeting and Clinical Experimental Medicine Expo (AACC) was successfully concluded at the Anaheim Convention Center in California, USA. AACC is the highest quality and largest annual event in the field of clinical testing in the world, attracting tens of thousands of international medical professionals from more than 100 countries every year, and is an important place and communication platform for the release of new products and cooperation in the field of clinical testing.

In this exhibition, Shenzhen Diasia Biomedical Technology Co., Ltd made its debut on the international stage with a number of easy test products, Dry Biochemical Analyzer,High Speed Multiplex Q-PCR, Fluorescence Immunochromatography Analyzer , WBC Analyzer, Urine Analyzer. These products with its ultra-portable, simple operation, accurate results and other characteristics, at the exhibition site to win many international customers.

Shenzhen DIASIA Biomedical Technology Co., Ltd. was founded in 2013. The company has been deeply involved in research and develop the IVD instruments and reagents for many years, in the areas for PCR technology, hematology analysis, clinical chemistry, immunofluorescence, pathological staining, rapid tests, Diasia has been constructing its medical products system, particularly developed the variety POCT machines and built the self-developed intelligent medical data management system. Diasia will continue to develop the technique and skills, at the same time provides better service for global partners. Diasia, as a Chinese enterprise who has a sense of mission, has been committing itslef to raise the ceiling on human health unremittingly, and will continue to work for it.